50 results
F-1
EX-3.1
KZIA
Kazia Therapeutics Limited
31 Jan 24
Registration statement (foreign)
12:00am
appointment or re-election; or
for more than three years, whichever is longer.
Retirement by rotation
21.2
While the Company is admitted to the Official List
F-3
KZIA
Kazia Therapeutics Limited
15 Dec 23
Shelf registration (foreign)
5:26pm
as our board thinks fit.
Retirement of Directors
Pursuant to our Constitution, at least one director, other than the Managing Director, must retire from
424B5
KZIA
Kazia Therapeutics Limited
4 Dec 23
Prospectus supplement for primary offering
4:05pm
.
Retirement of Directors
Pursuant to our Constitution and the ASX Listing Rules, at least one director, other than the managing director, must retire from
6-K
EX-99.1
KZIA
Kazia Therapeutics Limited
5 Sep 23
Current report (foreign)
7:02am
, a director is not re-elected to the Board after mandatory retirement and in particular, directly as a result of a corporate re-structuring … in Australian dollars using conversion rate of 0.7192. Pension amount is retirement benefit paid on employee’s behalf, paid in USD, but disclosed
6-K
EX-99.1
niju8 h8iu
1 May 23
Kazia Announces Executive Leadership Changes
7:14am
6-K
EX-99.1
025u2266uod6g e6
14 Oct 22
Current report (foreign)
7:05am
6-K
EX-99.4
tanul2ihru e98
1 Sep 22
Current report (foreign)
4:07pm
6-K
EX-99.1
ff8f4by29uwuiwh
1 Sep 22
Current report (foreign)
4:07pm
6-K
EX-1.1
caf2ae6usjkbvcyj36
22 Apr 22
Current report (foreign)
4:06pm
424B5
gxkb 8fqa2juub
22 Apr 22
Prospectus supplement for primary offering
4:04pm
6-K
wn3id1aqm0s
13 Oct 21
Current report (foreign)
6:07am
F-3
rg7cm naw677t
1 Sep 21
Shelf registration (foreign)
7:25am
424B5
ep2c3nr5e9
31 Mar 21
Prospectus supplement for primary offering
6:30am
6-K
m5kld
4 Jan 21
Current report (foreign)
6:05am